首页|埃索美拉唑治疗幽门螺杆菌阳性十二指肠溃疡患者的效果分析

埃索美拉唑治疗幽门螺杆菌阳性十二指肠溃疡患者的效果分析

扫码查看
目的 观察埃索美拉唑治疗幽门螺杆菌阳性十二指肠溃疡患者效果.方法 选取2016年2月~2016年12月浙江中医药大学附属第二医院收治的十二指肠溃疡患者77例作为研究样本,以抽签的方法随机分为观察组(n=34)和对照组(n=33).对照组予以雷尼替丁+阿莫西林+克拉霉素治疗,观察组予以埃索美拉唑+阿莫西林+克拉霉素治疗.对比2组患者临床症状缓解时间、生存质量情况、溃疡愈合情况、Hp根除率以及复发率.结果 观察组腹胀消失时间、腹痛消失时间均早于对照组,差异有统计学意义(P<0.05);观察组物质生活维度、躯体健康维度、心理健康维度、社会功能维度与对照组比较,差异有统计学意义(P<0.05);观察组溃疡愈合率为96.97%,远高于对照组的79.41%(P<0.05);观察组Hp根除率为96.97%,对照组Hp根除率为76.47%,2组比较差异有统计学意义(P<0.05).结论埃索美拉唑治疗幽门螺杆菌阳性十二指肠溃疡患者效果颇好.
Effect of esomeprazole in the treatment of Helicobacter pylori positive duodenal ulcer
Objective To observe the effect of esomeprazole in the treatment of Helicobacter pylori positive duodenal ulcer. Methods A total of 77 patients with duodenal ulcer treated in our hospital from February 2016 to December 2016 were randomly divided into observation group (n = 34) and control group (n = 33) , The control group was treated with ranitidine + amoxicillin + clarithromycin, the observation group was treated with esomeprazole+amoxicillin + clarithromycin.The clinical symptoms of remission time, quality of life, ulcer healing, Hp eradication rate and recurrence rate in two groups were compared. Results In the observation group, the disappearance time of abdominal distension and the time of disappearance of abdominal pain were earlier than those of the control group, the difference was statistically significant (P<0.05). There were significant differences in the physical dimension, the physical health dimension, the mental health dimension and the social function dimension between observation group and control group (P<0.05). The rate of ulcer healing was 96.97% in the observation group was higher than 79.41% in the control group (P<0.05). The rate of Hp eradication was 76.97% in the control group and 14.71% in the control group, the difference was statistically significant(P<0.05). Conclusion Esomeprazole treatment of Helicobacter pylori positive duodenal ulcer patients is quite effective.

esomeprazoleHelicobacter pylori positiveduodenal ulcer

倪思忆

展开 >

浙江中医药大学附属第二医院 消化内科,浙江 杭州 310005

埃索美拉唑 幽门螺杆菌阳性 十二指肠溃疡

浙江省中医药管理局浙江省科学技术厅资助项目

2010ZB0372015C33207

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(11)
  • 10